Since the registration system of gem, the issuing speed of new shares has been rapid. According to wind statistics, as of April 5, the number of registered new shares on GEM has reached 97, approaching 100, lasting less than eight months, while it took more than nine months for science and technology innovation board to gather 100 enterprises. Among the 97 stocks mentioned above, Golden Dragon (300999) ranked first with a market value of 448.9 billion yuan, followed by AMEC with a total market value of 101.3 billion yuan, and 8 stocks with a total market value of over 10 billion yuan, such as robust medical and Bertoni. In addition, some of the above-mentioned 97 stocks have disclosed their 2020 annual reports, and the net profits of four stocks, including China anda, have dropped by more than 10%.
There are 97 stocks in the new growth enterprise market
Since the listing of the first batch of gem registered enterprises on August 24, 2020, the team has expanded to 97 shares.
According to wind statistics, as of April 5, 97 shares under the gem registration system have successively landed in the A-share capital market, among which 63 shares such as Meichang shares, Tongniu information, Shanke intelligent and Yitian intelligent are listed from August 24 to December 31, 2020, and 34 shares such as Tongye technology, Yingli shares and AoYa design are listed from January 1 to April 5, 2021 There are 13 shares, 10 shares, 10 shares and 1 share listed.
Dongfang wealth data shows that many GEM stocks, such as CICC irradiation, Zhongzhou special materials, common pharmaceutical, HENGSHUAI, Hualv biology, Xiaoming, etc., completed their subscription at the end of March, and the company’s listing date is approaching, which also means that the number of listed companies under the gem registration system will soon exceed 100.
Compared with the expansion speed of science and technology innovation board, the growth enterprise board is faster. According to wind statistics, from July 22, 2019, when the first batch of listed enterprises landed on the science and technology innovation board, the number of enterprises in the board will reach 100 on April 29, 2020, taking more than 9 months. Wang Chikun, an independent economist, told Beijing Business Daily that since the registration system of the growth enterprise market, new share issuance has been arranged intensively. According to the current pace, the growth enterprise market issuance will still maintain a relatively fast speed.
In addition, according to the IPO arrangement, from April 6 to 9, a total of 5 shares of WanChen biology, legao food, Darui electronics, Shenzhen Ruijie and Xiangyuan new material will be applied for on the growth enterprise market, including Darui electronics and Shenzhen Ruijie.
Specifically, Darui electronics has an issue price of 168 yuan per share, with a market value of 130000 yuan for Dingge’s subscription. Roughly speaking, if the company rises by 100% on the first day of listing, Zhongyi investors can earn 84000 yuan. According to statistics, Fengshang culture has the highest issue price in the growth enterprise market, reaching 138 yuan per share. DARUI Electronics will also become the first high price stock in the growth enterprise market after it is listed.
The issue price of Shenzhen Ruijie is 89.66 yuan per share, and the market value of Dingge is 110000 yuan. If the company rises by 100% after going public, the investors in the first signing can earn 44800 yuan.
The total market value of 10 shares is over 10 billion yuan
Among the 97 shares registered on GEM, 10 shares, such as golden dragon fish and aimike, have a total market value of over 10 billion yuan.
According to statistics, the total market value of golden dragon fish is currently ranked first. As of the close of April 2, the total market value of the company is as high as 448.908 billion yuan. The total market value of Ningde is 774.3 billion yuan, second only to that of Jinlong. Throughout the A-share market, the total market value of golden dragon fish is ranked 24th.
The second is aimec, with a total market value of 101.256 billion yuan. Among the 97 shares, there are only two shares, Jinlongyu and aimike, with a total market value of more than 100 billion yuan. According to the data, AMEC landed in the A-share market on September 28, 2020. The company is an innovative enterprise in the field of biomedical soft tissue repair materials in China, known as the leader of hyaluronic acid in A-share market. At present, its main products are sodium hyaluronate products for injection of class III medical device series, facial implant line products, and derived brand matrix “companion” cosmetics.
It is worth mentioning that in February this year, the company once became the first 1000 yuan stock in the growth enterprise market after the disclosure of the bright plan of sending 35 yuan for 10 transfers and 8 dividends.
In addition to golden dragon fish and AMEC, the total market value of 8 shares, namely, Bertoni, Anke innovation, robust medical, Zhongwei, Kangtai medical, Meichang, Martian and Ruifeng new material, is also more than 10 billion yuan, which are 74.77 billion yuan, 63.842 billion yuan, 59.922 billion yuan, 46.335 billion yuan, 30.794 billion yuan, 22.513 billion yuan, 20.971 billion yuan and 12.138 billion yuan respectively.
Among the above-mentioned 10 shares, only betaine will be listed this year, and the remaining 9 shares will be listed from August 24 to December 31, 2020.
From the perspective of stock price, as of April 2, among the gem registered stocks, six stocks, including aimike, betaine, Anke innovation, robust medical, Fengshang culture and Hengyu Xintong, had more than 100 shares. Among them, the issuing prices of aimike and Fengshang culture exceeded 100 yuan. Betaine and Hengyu Xintong were listed for a short time. Among them, Hengyu Xintong was just listed on April 2 and closed up 108% on the first day of listing, The share price was 128.38 yuan per share.
Net profit of 4 shares fell by more than 10% last year
Among the above 97 shares, 27 have disclosed the company’s annual report or performance express in 2020, and the net profit of 4 shares of China anda, Blue Shield optoelectronics, Huaye spice and Yingli has dropped by more than 10%.
Specifically, among the 27 shares that disclosed their performance in 2020, 19 shares, such as Jinchun, Huisheng biology, Zhenyu technology, Haichen and Jiaheng Jiahua, showed a year-on-year increase in net profit in 2020. Among them, the net profit of Jinchun and Huisheng biology increased by more than 100%. During the reporting period, the net profit attributable to the two companies was about 276 million yuan and 150 million yuan respectively, with a year-on-year increase of 212.35% and 118.36% respectively.
In addition, the net profit of Fengshang culture, Bojun technology and Weikang pharmaceutical will increase by less than 10% in 2020, and the net profit of the remaining 14 shares will increase by 10% – 100%.
In contrast, the net profits of 8 shares, such as guoanda, Landun optoelectronics, AoYa design and degut, are in a downward trend in 2020. The net profits of 4 shares, such as guoanda, Landun optoelectronics, Huaye spice and Yingli, are down by more than 10%. The net profits of the remaining 4 shares, such as Tongye technology, degut, Shenshui Haina and AoYa design, are all down by no more than 10%.
So far, the net profit of guoanda has declined the most. According to the data, guoanda landed on the gem on October 29, 2020. The company is one of the main suppliers of automatic fire extinguishing system in the domestic transportation and power grid industries. In 2020, the company’s operating revenue is about 276 million yuan, a year-on-year decrease of 0.57%; the corresponding net profit is about 62.1208 million yuan, a year-on-year decrease of 16.69%. In response to related issues, Beijing Business Daily reporter called the office of secretary of guoanda for an interview, but no one answered the phone.
On August 24, September 16, 2020 and March 26, 2021, respectively, Blue Shield optoelectronics, Huaye spices and Yingli Co., Ltd. landed in the A-share market. The net profit of the company in 2020 was about 130 million yuan, 40.22 million yuan and 99.54 million yuan, respectively, with a year-on-year decrease of 14.9%, 12.12% and 10.21%.
Xu Xiaoheng, a senior investment and financing expert, said in an interview with Beijing Business Daily that due to the epidemic situation, many enterprises will see a slight decline in their performance in 2020, which is understandable. Investors should focus on the reasons for the decline.
Beijing Business Daily reporter Dong Liangma
[the above content is transferred from “Beijing Business Daily website”, which does not represent the view of this website. If you need to reprint it, please get permission from the website of Beijing business daily. If there is any infringement, please contact to delete it. 】